FDA Approval of Breast Cancer Vaccine
The FDA recently opened the door for a phase 1 of a particular type of breast cancer vaccine to begin this spring. This Phase 1 clinical trial of the vaccine was approved for use in humans with triple negative breast cancer, considered to be one of the most difficult types of breast cancers to treat. As a patient advocate, the FDA approval of the phase 1 clinical trial for this breast cancer vaccine comes as good news. There are various types of breast cancer. A majority, around 80%, are estrogen receptor positive often referred as ER+. This means the cancer cells grow in response to the hormone estrogen. Women and men who have breast cancers that are ER/PR+ are prescribed medication that blocks the hormone receptors, preventing hormones from binding to them thus helping the breast cancer from coming back. A pathology report for what type of breast cancer you Continue Reading →